187 related articles for article (PubMed ID: 8403679)
1. [Coagulation and fibrinolytic parameters in patients with various angiopathies--analysis in cerebral thrombosis, diabetic and vasculitic neuropathies].
Kohriyama T; Katayama S; Tanaka E; Yamamura Y; Nakamura S
Rinsho Shinkeigaku; 1993 Jun; 33(6):606-11. PubMed ID: 8403679
[TBL] [Abstract][Full Text] [Related]
2. [Antiplatelet therapy in patients with cerebral thrombosis at the chronic phase--assessment of its effect on coagulation and fibrinolytic parameters].
Kohriyama T; Tanaka E; Katayama S; Yamamura Y; Nakamura S
Rinsho Shinkeigaku; 1994 Aug; 34(8):771-6. PubMed ID: 7994982
[TBL] [Abstract][Full Text] [Related]
3. Von Willebrand factor in diabetic angiopathy.
Kessler L; Wiesel ML; Attali P; Mossard JM; Cazenave JP; Pinget M
Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
[TBL] [Abstract][Full Text] [Related]
4. Factor VIII, von Willebrand factor and platelet adhesiveness in diabetic retinopathy.
Nozaki H; Hiramatsu K; Arimori S
Tokai J Exp Clin Med; 1987 Mar; 12(1):7-9. PubMed ID: 3130682
[TBL] [Abstract][Full Text] [Related]
5. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
Christe M; Fritschi J; Lämmle B; Tran TH; Marbet GA; Berger W; Duckert F
Thromb Haemost; 1984 Oct; 52(2):138-43. PubMed ID: 6084321
[TBL] [Abstract][Full Text] [Related]
6. Possible involvement of Von Willebrand factor in pancreatic graft thrombosis after kidney-pancreas transplantation: a retrospective study.
Kessler L; Wiesel ML; Boudjema K; Lutun E; Moulin B; Cazenave JP; Wolf P; Pinget M
Clin Transplant; 1998 Feb; 12(1):35-42. PubMed ID: 9541421
[TBL] [Abstract][Full Text] [Related]
7. Plasma coagulation and fibrinolysis parameters in patients with collagen diseases, and analysis of the multimeric structure of von Willebrand factor (vWF).
Kagawa H; Okubo S; Yasunaga K
Int J Hematol; 1991 Oct; 54(5):429-39. PubMed ID: 1756253
[TBL] [Abstract][Full Text] [Related]
8. Coagulation in diabetic and non-diabetic claudicants.
Gosk-Bierska I; Adamiec R; Alexewicz P; Wysokinski WE
Int Angiol; 2002 Jun; 21(2):128-33. PubMed ID: 12110772
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
Budde U; Metzner HJ; Müller HG
Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
[TBL] [Abstract][Full Text] [Related]
10. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
[TBL] [Abstract][Full Text] [Related]
11. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
[TBL] [Abstract][Full Text] [Related]
12. [Significance of the coagulation and fibrinolytic parameters as predictors for carotid atherosclerosis].
Nomura E; Kohriyama T; Yamaguchi S; Kajikawa H; Nakamura S
Rinsho Shinkeigaku; 1996 Jun; 36(6):741-5. PubMed ID: 8937194
[TBL] [Abstract][Full Text] [Related]
13. The effect of diabetes regulation on platelet release, fibrinolysis and coagulation tests, before and after stimulation with DDAVP.
vd Knaap JH; de Boer AC; Pannebakker MA; van Heerde W; den Ottolander GJ
Thromb Haemost; 1985 Feb; 53(1):118-21. PubMed ID: 3922075
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
[TBL] [Abstract][Full Text] [Related]
15. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
16. Quantitative and qualitative assessment of plasma von Willebrand factor variations, as induced by forearm venous stasis in patients with diabetic microangiopathy.
Porta M; Ricchetti I; La Selva M; Bertagna A; Molinatti GM
Diabetes Res; 1984 Nov; 1(4):219-21. PubMed ID: 6442228
[TBL] [Abstract][Full Text] [Related]
17. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
18. von Willebrand factor and factor VIII: C in acute cerebrovascular disease. Relationship to stroke subtype and mortality.
Catto AJ; Carter AM; Barrett JH; Bamford J; Rice PJ; Grant PJ
Thromb Haemost; 1997 Jun; 77(6):1104-8. PubMed ID: 9241740
[TBL] [Abstract][Full Text] [Related]
19. [Plasma coagulation and fibrinolysis parameters in patients with vascular Behçet's disease, and analysis of the multimeric structure of von Willebrand factor (vWF)].
Kagawa H; Okubo S
Ryumachi; 1993 Oct; 33(5):416-23. PubMed ID: 8256164
[TBL] [Abstract][Full Text] [Related]
20. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
Escolar G; Carretero M; Magallón M; Quintana M; Arnau C; Castillo R; Aznar-Salatti J
Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
